U.K. Pharmaceuticals & Biotech High ROE Growth Engines

HUTCHMED (China)

Market Cap: UK£1.5b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.